Revolade approved for use in hepatitis C... - Hepatitis C Trust

Hepatitis C Trust

745 members467 posts

Revolade approved for use in hepatitis C therapy

Hep_C_News_team profile image
0 Replies

GlaxoSmithKline has announced its platelet-boosting drug Revolade has gained EU approval for treating patients with the hepatitis C virus. Read our article on the news here:

hepatitiscnews.com/revolade...

Written by
Hep_C_News_team profile image
Hep_C_News_team
To view profiles and participate in discussions please or .
Read more about...